MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,172,820 | -22.2% | 10,217,282 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $131,247,960 | -11.3% | 10,558,967 | -0.0% | 0.00% | -25.0% |
| Q1 2023 | $147,934,350 | -0.5% | 10,559,197 | +1.6% | 0.00% | 0.0% |
| Q4 2022 | $148,680,599 | -43.0% | 10,389,979 | +1.7% | 0.00% | -50.0% |
| Q3 2022 | $260,728,000 | -12.0% | 10,212,598 | -2.1% | 0.01% | 0.0% |
| Q2 2022 | $296,402,000 | -20.1% | 10,433,033 | -0.8% | 0.01% | -11.1% |
| Q1 2022 | $370,766,000 | -16.0% | 10,512,217 | -0.2% | 0.01% | -10.0% |
| Q4 2021 | $441,359,000 | -11.0% | 10,533,609 | +4.2% | 0.01% | -16.7% |
| Q3 2021 | $496,048,000 | +42.4% | 10,106,939 | +21.1% | 0.01% | +33.3% |
| Q2 2021 | $348,393,000 | +82.5% | 8,348,750 | +55.9% | 0.01% | +80.0% |
| Q1 2021 | $190,908,000 | +44.4% | 5,356,554 | +13.6% | 0.01% | +25.0% |
| Q4 2020 | $132,212,000 | – | 4,713,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |